Author:
Sakai-Kato Kumiko,Nishiyama Nobuhiro,Kozaki Masato,Nakanishi Takeshi,Matsuda Yoshihiro,Hirano Mai,Hanada Hiroyuki,Hisada Shigeru,Onodera Hiroshi,Harashima Hideyoshi,Matsumura Yasuhiro,Kataoka Kazunori,Goda Yukihiro,Okuda Haruhiro,Kawanishi Toru
Funder
Research on Development of New Drugs, Health and Labour Sciences Research Grant,
Initiative for Accelerating Regulatory Science in Innovative Drug, Medical Device, and Regenerative Medicine
Reference76 articles.
1. Doxil®—the first FDA-approved nano-drug: lessons learned;Barenholz;J. Control. Release,2012
2. Nanomedicine(s) under the microscope;Duncan;Mol. Pharm.,2011
3. Considering whether an FDA-regulated product involves the application of nanotechnology;Guidance for Industry,2014
4. Cancer nanotechnology: opportunities and challenges;Ferrari;Nat. Rev. Cancer,2005
5. Drug nanocrystals: in vivo performances;Gao;J. Control. Release,2012
Cited by
64 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献